menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Mithra sells Estetra SRL, Neuralis SA and specific assets to Gedeon Richter

    PRESS RELEASE

    Mithra files for bankruptcy and continues negotiations with Gedeon Richte

    PRESS RELEASE

    Mithra applies for extension of court protection measures to advance process

    PRESS RELEASE

    Mithra receives additional EUR 2.5 million to advance monetization

    PRESS RELEASE

    Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®

    PRESS RELEASE

    Mithra enters into exclusive negotiations with Gedeon Richter

    PRESS RELEASE

    Mithra updates on offers received in the context of its monetization process

    PRESS RELEASE

    Early data from Mithra’s ESTELLE® pediatric study at two upcoming congresses

    PRESS RELEASE

    Mithra updates on its ongoing monetization process

    PRESS RELEASE

    Mithra announces updates to its 2024 financial calendar

    PRESS RELEASE

    Mithra reaches milestone in estetrol skin study

    PRESS RELEASE

    Mithra gears up to enter the immune-oncology race

    CLINICAL TRIALS ARENA

    Publication of a transparency notification received from Scorpiaux BV

    PRESS RELEASE

    Mithra Appoints Executive Christian Homsy as Chairman

    PRESS RELEASE

    Mithra’s Meeting Approves the Renewal of its Board of Directors

    PRESS RELEASE

    Payment of the interests of the Highbridge/Whitebox loans

    PRESS RELEASE

    Mithra announces completion of recruitment in study of Estelle in patients

    PRESS RELEASE

    Mithra and the University of Liège Secure Proof-of-Concept for E4

    PRESS RELEASE

    Publication of a transparency notification received from Alychlo NV

    PRESS RELEASE

    Mithra Releases Invitation to its General Shareholders’ Meeting

    PRESS RELEASE

    Mithra releases 2022 Annual Report

    PRESS RELEASE

    FDA approval, partnership on agenda at Mithra as phase 3 hits

    FIERCEBIOTECH

    Mithra Provides FDA Update on Myring

    MARKETSCREENER

    Mithra and Searchlight Pharma Announce Availability of Nextstellis

    NEWSWIRE

    ExeVir and Mithra announce manufacturing collaboration

    PR NEWSWIRE

    Mithra Signs License & Supply Agreement Commercialization of Myring in Mexico

    PRESS RELEASE

    Mayne, Mithra bring novel oral contraception in the US

    PRNASIA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.